Safety Profile of Lithium: A Disproportionality Analysis Using the FDA Adverse Event Reporting System
By analyzing real-world data, this study provides a comprehensive evaluation of lithium's safety profile, offering critical evidence for its clinical risk. However, given the inherent limitations of FAERS, such as underreporting of minor symptoms, the findings should be interpreted cautiously. .
Authors
- Patrick Ip (ORCID: https://orcid.org/0000-0002-6797-6898)
- Jeff Jianfei Guo (ORCID: https://orcid.org/0000-0002-1177-4146)
- Hao Zhu (ORCID: https://orcid.org/0000-0002-8417-9698)
- Hock Foong Lui
Institutions
- University of Illinois Urbana-Champaign (US)
- University of Hong Kong (HK)
Publication Details
- Journal
- Neuropsychobiology
- Published
- 2025-05-30
- DOI
- https://doi.org/10.1159/000546602
- Primary Topic
- Pharmacovigilance and Adverse Drug Reactions
- Type
- article
- Field-Weighted Citation Impact
- 0.00